Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zevex International Inc.

Division of Moog Inc.
www.zevex.com

Latest From Microvena Corp.

ev3: The Virtues of Focus

Six years ago, ev3 was launched aiming at a broad attach on cardio- and endovascular disease. But the company found including coronary devices in its mix too difficult and too costly. Instead, the company shifted directions three years ago, with a focus on peripheral and neurovascular disease. In the process, it hopes to address what it calls "the innovation gap," the lack of devices developed specifically for the PVD and neurovascular specialists.
Medical Device Strategy

Guidant Pioneers Stents' Move North to Carotids

Stenting moves from coronaries to carotids to do for stroke what these devices did for heart attacks. This new endovascular approach has surgeons switching, not fighting.
Medical Device Clinical Trials

Embolic Protection: Better Outcomes Not Enough

For 20 years, interventional cardiologists denied the need for embolic protection devices, considering embolic events to generally be the infrequent results of poor technique. Nevertheless, recent data has revealed embolization as a potentially serious and relatively common event during percutaneous coronary interventions. While embolic protection devices have been shown to dramatically reduce embolic complications, physician adoption is slow. Several companies are developing different approaches to protect against embolization, recognizing that better patient data alone isn't enough to convince interventionalists to employ these devices.
Medical Device Strategy

Kerberos Proximal Solutions Inc.

Kerberos' KEPTembolic protection catheter system uses an alternating rinsing and aspiration action -- "Rinspiration" -- to capture and retrieve more embolic mass, including small particles.
Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Medical Devices
    • Consumables, Central Supplies
    • Monitoring Equipment & Devices
    • Surgical Equipment & Devices
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Moog Inc.
  • Senior Management
  • David J McNally, Pres. & CEO
    Phillip L McStotts, CFO
    Shawn Fojtik, VP, Sales & Mktg.
  • Contact Info
  • Zevex International Inc.
    Phone: (801) 264-1001
    4314 Zevex Park Lane
    Salt Lake City, UT 84123
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register